Bian et al., 2021 - Google Patents
On-site biolayer interferometry-based biosensing of carbamazepine in whole blood of epileptic patientsBian et al., 2021
View HTML- Document ID
- 4633071529503611353
- Author
- Bian S
- Tao Y
- Zhu Z
- Zhu P
- Wang Q
- Wu H
- Sawan M
- Publication year
- Publication venue
- Biosensors
External Links
Snippet
On-site monitoring of carbamazepine (CBZ) that allows rapid, sensitive, automatic, and high- throughput detection directly from whole blood is of urgent demand in current clinical practice for precision medicine. Herein, we developed two types (being indirect vs. direct) of …
- 229960000623 carbamazepine 0 title abstract description 126
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shao et al. | Rapid and sensitive lateral flow immunoassay method for procalcitonin (PCT) based on time-resolved immunochromatography | |
Real-Fernández et al. | Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance | |
Hu et al. | Comparison of surface plasmon resonance, resonant waveguide grating biosensing and enzyme linked immunosorbent assay (ELISA) in the evaluation of a dengue virus immunoassay | |
Choudhary et al. | Development of a point-of-care SPR sensor for the diagnosis of acute myocardial infarction | |
Garyfallou et al. | Electrochemical detection of plasma immunoglobulin as a biomarker for Alzheimer’s disease | |
Bian et al. | On-site biolayer interferometry-based biosensing of carbamazepine in whole blood of epileptic patients | |
Han et al. | Validation of a novel modified aptamer-based array proteomic platform in patients with end-stage renal disease | |
Santamaría et al. | Development towards compact nitrocellulose-based interferometric biochips for dry eye MMP9 label-free in-situ diagnosis | |
Braz et al. | Graphene-binding peptide in fusion with SARS-CoV-2 antigen for electrochemical immunosensor construction | |
Dai et al. | In vitro quantified determination of β-amyloid 42 peptides, a biomarker of neuro-degenerative disorders, in PBS and human serum using a simple, cost-effective thin gold film biosensor | |
Li et al. | Real-time tau protein detection by sandwich-based piezoelectric biosensing: exploring tubulin as a mass enhancer | |
Tomassetti et al. | A new surface plasmon resonance immunosensor for triazine pesticide determination in bovine milk: a comparison with conventional amperometric and screen-printed immunodevices | |
Lee et al. | Development of an electrochemical immunosensor for detection of cardiac troponin I at the point-of-care | |
D’Urso et al. | Therapeutic drug monitoring of antiseizure medications using volumetric absorptive microsampling: where are we? | |
Ganguly et al. | Label free, lateral flow prostaglandin E2 electrochemical immunosensor for urinary tract infection diagnosis | |
Nguyen et al. | Electrochemical DNA biosensor that detects early celiac disease autoantibodies | |
Ameku et al. | Rapid detection of anti-SARS-CoV-2 antibodies with a screen-printed electrode modified with a spike glycoprotein epitope | |
Canovi et al. | A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of pentraxin-3 in human plasma | |
Arcadio et al. | Estradiol detection for aquaculture exploiting plasmonic spoon-shaped biosensors | |
Sankiewicz et al. | An immunosensor for the determination of cortisol in serum and saliva by array SPRi | |
Trzaskowski et al. | Portable surface plasmon resonance detector for COVID-19 Infection | |
Vlcnovska et al. | Comparison of metal nanoparticles (Au, Ag, Eu, Cd) used for immunoanalysis using LA-ICP-MS detection | |
Bhardwaj et al. | Comparison of proteomic technologies for blood-based detection of colorectal cancer | |
Simonini et al. | CSF heavy neurofilament may discriminate and predict Motor Neuron Diseases with Upper Motor Neuron involvement | |
Koh et al. | Development of monitoring system for assessing rheumatoid arthritis within 5 minutes using a drop of bio-fluids |